Mark L. Sandberg

1.0k citations

19 papers · 815 indexed · h-index 13

Co-authors: Bill Sugden Wolfgang Hammerschmidt Michael P. Cooke Susan Sutton Mathew T. Pletcher Lisa M. Tarantino Tim Wiltshire John B. Hogenesch
Topics: CAR-T cell therapy research (6 papers)Immune Cell Function and Interaction (5 papers)Viral-associated cancers and disorders (4 papers)
Cited by: Oncology Immunology Pathology and Forensic Medicine
Journals: Nature Immunology PLoS ONE Biochemistry
Partner nations: United States Switzerland Germany

In The Last Decade

Mark L. Sandberg

19 papers receiving 803 citations

Peers

Countries citing papers authored by Mark L. Sandberg

Since Specialization

Citations

This map shows the geographic impact of Mark L. Sandberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Sandberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Sandberg more than expected).

Fields of papers citing papers by Mark L. Sandberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. Sandberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Sandberg. The network helps show where Mark L. Sandberg may publish in the future.

Co-authorship network of co-authors of Mark L. Sandberg

This figure shows the co-authorship network connecting the top 25 collaborators of Mark L. Sandberg. A scholar is included among the top collaborators of Mark L. Sandberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark L. Sandberg. Mark L. Sandberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Geometric parameters that affect the behavior of logic-gated CAR T cells 2024 ·Frontiers in Immunology ·(unknown),(unknown),Sanam Shafaattalab,Erica R. Vander Mause,Aaron Winters,Mark Daris,(unknown),Claudia A. Jette,Breanna DiAndreth,Mark L. Sandberg,Agnes E. Hamburger,Alexander Kamb,Timothy P. Riley	5
2	A carcinoembryonic antigen-specific cell therapy selectively targets tumor cells with HLA loss of heterozygosity in vitro and in vivo 2022 ·Science Translational Medicine ·Mark L. Sandberg,(unknown),(unknown),(unknown),(unknown),(unknown),Michele McElvain,(unknown),Sanam Shafaattalab,Sara Martire,F. Fisher,(unknown),Edwin Liu,David Ju,Lu Min Wong,Xu Han,Alexander Kamb	41
3	Extensive functional comparisons between chimeric antigen receptors and T cell receptors highlight fundamental similarities 2021 ·Molecular Immunology ·Xueyin Wang,(unknown),(unknown),Michele McElvain,Julyun Oh,(unknown),(unknown),(unknown),(unknown),Dora Toledo Warshaviak,Mark L. Sandberg,Xu Han,Alexander Kamb	6
4	Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers 2021 ·Journal of Immunotherapy ·Xueyin Wang,Mark L. Sandberg,(unknown),(unknown),(unknown),(unknown),(unknown),Michele McElvain,Dora Toledo Warshaviak,(unknown),Julyun Oh,Mark Daris,(unknown),Christine Yao,(unknown),Craig R. Pigott,Alexander Kamb,Xu Han	19
5	Structure-function relationships of chimeric antigen receptors in acute T cell responses to antigen 2020 ·Molecular Immunology ·Xu Han,Agnes E. Hamburger,(unknown),Xueyin Wang,(unknown),Talar Tokatlian,Julyun Oh,Mark Daris,(unknown),(unknown),(unknown),(unknown),Grace E. Asuelime,Michele McElvain,Mark L. Sandberg,Alexander Kamb	14
6	125 Reexamination of MAGE-A3 as a T-cell Therapeutic Target 2020 ·Regular and Young Investigator Award Abstracts ·(unknown),Xueyin Wang,Xu Han,Alexander Kamb,Mark L. Sandberg,(unknown),(unknown),Dora Toledo Warshaviak,(unknown),Michele McElvain,Mark Daris,(unknown)	1
7	Isolation and Characterization of a Distinct Subpopulation from the WM115 Cell Line That Resembles In Vitro Properties of Melanoma Cancer Stem Cells 2017 ·SLAS DISCOVERY ·(unknown),Mark H. Chin,Mark L. Sandberg,Han Xu	3
8	Inhibition of the Inositol Kinase Itpkb Augments Calcium Signaling in Lymphocytes and Reveals a Novel Strategy to Treat Autoimmune Disease 2015 ·PLoS ONE ·Andrew T. Miller,Carol Dahlberg,Mark L. Sandberg,Ben G. Wen,Daniel R. Beisner,John A. H. Hoerter,Albert E. Parker,Christian Schmedt,Monique Stinson,(unknown),(unknown),Mark J. McPate,Pamela Tranter,Martin Gosling,Paul J. Groot‐Kormelink,Janet Dawson,Shifeng Pan,Shin‐Shay Tian,H. Martin Seidel,Michael P. Cooke	15
9	Discovery of pyrimidine benzimidazoles as Src-family selective Lck inhibitors. Part II 2009 ·Bioorganic & Medicinal Chemistry Letters ·Guobao Zhang,Pingda Ren,Nathanael S. Gray,Taebo Sim,Xia Wang,Yi Liu,Jianwei Che,(unknown),(unknown),Mark L. Sandberg,Tracy A. Spalding,Russell D. Romeo,Maya Iskandar,Zhiliang Wang,H. Martin Seidel,Donald S. Karanewsky,Yun He	5
10	Phosphoinositide and Inositol Phosphate Analysis in Lymphocyte Activation 2009 ·Current Protocols in Immunology ·Karsten Sauer,Yina H. Huang,Hongying Lin,Mark L. Sandberg,Georg W. Mayr	21
11	Discovery of 2-amino-6-carboxamidobenzothiazoles as potent Lck inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Shenlin Huang,Zuosheng Liu,Shin‐Shay Tian,Mark L. Sandberg,Tracy A. Spalding,Russell D. Romeo,Maya Iskandar,Zhiliang Wang,Donald S. Karanewsky,Yun He	5
12	Discovery of pyrimidine benzimidazoles as Lck inhibitors: Part I 2008 ·Bioorganic & Medicinal Chemistry Letters ·Guobao Zhang,Pingda Ren,Nathanael S. Gray,Taebo Sim,Yi Liu,Xia Wang,Jianwei Che,(unknown),Mark L. Sandberg,Tracy A. Spalding,Russell D. Romeo,Maya Iskandar,Donald Chow,H. Martin Seidel,Donald S. Karanewsky,Yun He	26
13	Production of Ins(1,3,4,5)P4 mediated by the kinase Itpkb inhibits store-operated calcium channels and regulates B cell selection and activation 2007 ·Nature Immunology ·Andrew T. Miller,Mark L. Sandberg,Yina H. Huang,Michael A. Young,Susan Sutton,Karsten Sauer,Michael P. Cooke	65
14	c-Myb and p300 Regulate Hematopoietic Stem Cell Proliferation and Differentiation 2005 ·Developmental Cell ·Mark L. Sandberg,Susan Sutton,Mathew T. Pletcher,Tim Wiltshire,Lisa M. Tarantino,John B. Hogenesch,Michael P. Cooke	218
15	Structural Insights into Enzyme Regulation for Inositol 1,4,5-Trisphosphate 3-Kinase B 2005 ·Biochemistry ·Philip P. Chamberlain,Mark L. Sandberg,Karsten Sauer,M. Cooke,Scott A. Lesley,Glen Spraggon	23
16	High Physiological Levels of LMP1 Result in Phosphorylation of eIF2α in Epstein-Barr Virus-Infected Cells 2004 ·Journal of Virology ·(unknown),Mark L. Sandberg,Bill Sugden	51
17	Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus. 2003 ·PubMed ·Ulrike Dirmeier,Bernhard Neuhierl,Ellen Kilger,G. Reisbach,Mark L. Sandberg,Wolfgang Hammerschmidt	116
18	Latent Membrane Protein 1 of Epstein-Barr Virus Inhibits as Well as Stimulates Gene Expression 2000 ·Journal of Virology ·Mark L. Sandberg,Ajamete Kaykas,Bill Sugden	25
19	Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3 1997 ·Journal of Virology ·Mark L. Sandberg,Wolfgang Hammerschmidt,Bill Sugden	156

About Mark L. Sandberg

Mark L. Sandberg is a scholar working on Oncology, Immunology and Sensory Systems, having authored 19 papers that have together received 815 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (5 papers) and Viral-associated cancers and disorders (4 papers). The work is most often cited by research in Oncology (414 citations), Immunology (252 citations) and Pathology and Forensic Medicine (153 citations). Mark L. Sandberg has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Bill Sugden, Wolfgang Hammerschmidt, Michael P. Cooke, Susan Sutton, Mathew T. Pletcher, Lisa M. Tarantino, Tim Wiltshire, John B. Hogenesch, Ellen Kilger and G. Reisbach. Their work appears in journals such as Nature Immunology, PLoS ONE and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact